ProFibrix Reports Phase II Results Of Hemostasis Product Fibrocaps(TM) And Appoints New Chief Medical Officer
LEIDEN, The Netherlands and SEATTLE, Washington, March 11, 2010 /PRNewswire/ -- ProFibrix B.V., a leader in the development of innovative products for hemostasis and regenerative medicine, today…